Literature DB >> 24088157

Physicians under the influence: social psychology and industry marketing strategies.

Sunita Sah1, Adriane Fugh-Berman.   

Abstract

Pharmaceutical and medical device companies apply social psychology to influence physicians' prescribing behavior and decision making. Physicians fail to recognize their vulnerability to commercial influences due to self-serving bias, rationalization, and cognitive dissonance. Professionalism offers little protection; even the most conscious and genuine commitment to ethical behavior cannot eliminate unintentional, subconscious bias. Six principles of influence - reciprocation, commitment, social proof, liking, authority, and scarcity - are key to the industry's routine marketing strategies, which rely on the illusion that the industry is a generous avuncular partner to physicians. In order to resist industry influence, physicians must accept that they are vulnerable to subconscious bias and have both the motivation and means to resist industry influence. A culture in which accepting industry gifts engenders shame rather than gratitude will reduce conflicts of interest. If greater academic prestige accrues to distant rather than close relationships with industry, then a new social norm may emerge that promotes patient care and scientific integrity. In addition to educating faculty and students about the social psychology underlying sophisticated but potentially manipulative marketing and about how to resist it, academic medical institutions should develop strong organizational policies to counteract the medical profession's improper dependence on industry.
© 2013 American Society of Law, Medicine & Ethics, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 24088157     DOI: 10.1111/jlme.12076

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  25 in total

1.  The Effects of Public Disclosure of Industry Payments to Physicians on Patient Trust: A Randomized Experiment.

Authors:  Alison R Hwong; Sunita Sah; Lisa Soleymani Lehmann
Journal:  J Gen Intern Med       Date:  2017-07-17       Impact factor: 5.128

2.  Physician-Industry Interactions and Anti-Vascular Endothelial Growth Factor Use Among US Ophthalmologists.

Authors:  Stanford C Taylor; Julia B Huecker; Mae O Gordon; David E Vollman; Rajendra S Apte
Journal:  JAMA Ophthalmol       Date:  2016-08-01       Impact factor: 7.389

3.  How to make opinion leaders and influence people.

Authors:  Sergio Sismondo
Journal:  CMAJ       Date:  2015-07-06       Impact factor: 8.262

4.  Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States.

Authors:  Marissa King; Peter S Bearman
Journal:  Soc Sci Med       Date:  2016-11-09       Impact factor: 4.634

5.  The ethical challenges in rheumatology.

Authors:  Emily J Mckeown
Journal:  Curr Rev Musculoskelet Med       Date:  2015-06

6.  The Receipt of Industry Payments is Associated With Prescribing Promoted Alpha-blockers and Overactive Bladder Medications.

Authors:  Parth K Modi; Ye Wang; Peter S Kirk; James M Dupree; Eric A Singer; Steven L Chang
Journal:  Urology       Date:  2018-04-20       Impact factor: 2.649

7.  The Role of Regional Conferences in Research Resident Career Development: The California Psychiatry Research Resident Retreat.

Authors:  Aaron D Besterman; Jody K Williams; Victor I Reus; Michele T Pato; Susan M Voglmaier; Carol A Mathews
Journal:  Acad Psychiatry       Date:  2016-05-13

8.  How do we know what we know?

Authors:  Arundhati Dhara
Journal:  Can Fam Physician       Date:  2021-11       Impact factor: 3.275

9.  Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.

Authors:  Aaron P Mitchell; Akriti Mishra; Pranam Dey; Michael A Curry; Niti U Trivedi; Michael Haddadin; Mohammed W Rahman; Aaron N Winn; Stacie B Dusetzina; Peter B Bach
Journal:  Oncologist       Date:  2021-05-26

Review 10.  The emerging diabetes online community.

Authors:  Marisa E Hilliard; Kerri M Sparling; Jeff Hitchcock; Tamara K Oser; Korey K Hood
Journal:  Curr Diabetes Rev       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.